ImmunityBio (IBRX) Exchange Rate Effect (2020 - 2026)
ImmunityBio (IBRX) reported Exchange Rate Effect of $122000.0 for Q1 2026, up 1320.0% year-over-year from $8591.5 in Q1 2025, and up 2340.0% on a QoQ basis from $5000.0 in Q4 2025.
ImmunityBio (IBRX) has 7 years of Exchange Rate Effect data on file, last reported at $122000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 1320.0% year-over-year to $122000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147000.0 (up 2350.0% YoY) and the FY2025 annual result came in at $15000.0, up 165.22% from the prior year.
- Exchange Rate Effect grew to $122000.0 in Q1 2026 per IBRX's latest filing, from $5000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $255000.0 in Q2 2022 and bottomed at -$254000.0 in Q1 2023.
- The 5-year median for Exchange Rate Effect is -$1000.0 (2023), against an average of $6235.3.
- The widest annual swing landed in 2025, when Exchange Rate Effect slumped 609.09%; it then jumped 1320.0% in 2026.
- Tracing IBRX's Exchange Rate Effect over 5 years: stood at $161000.0 in 2022, then slumped by 116.77% to -$27000.0 in 2023, then soared by 74.07% to -$7000.0 in 2024, then surged by 171.43% to $5000.0 in 2025, then soared by 2340.0% to $122000.0 in 2026.
- Per Business Quant, the three latest IBRX Exchange Rate Effect figures stand at $122000.0 (Q1 2026), $5000.0 (Q4 2025), and -$56000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | 122,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122,000.00 |
| Mar 31, 2026 | 122,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Sep 30, 2025 | -56,000.00 |
| Jun 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 76,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Mar 31, 2024 | -39,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Dec 31, 2023 | -27,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | -254,000.00 |
| Mar 31, 2023 | -254,000.00 |
| Dec 31, 2022 | 161,000.00 |
| Dec 31, 2022 | 161,000.00 |
| Sep 30, 2022 | 43,000.00 |
| Sep 30, 2022 | 43,000.00 |
| Jun 30, 2022 | 255,000.00 |
| Jun 30, 2022 | 255,000.00 |
| Mar 31, 2022 | -175,000.00 |
| Mar 31, 2022 | -175,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 48,000.00 |
| Mar 31, 2021 | -109,000.00 |
| Mar 31, 2021 | -109,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | -78,000.00 |
| Sep 30, 2020 | -78,000.00 |
| Jun 30, 2020 | -84,000.00 |
| Jun 30, 2020 | -84,000.00 |
| Mar 31, 2020 | 89,000.00 |
| Mar 31, 2020 | 89,000.00 |